Alexander Mayweg's most recent trade in Monte Rosa Therapeutics Inc was a trade of 20,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Dr. Alexander Mayweg, PhD | Director | 14 Jun 2023 | 20,500 | 20,500 | - | - | Stock Option (Right to Buy) | ||
| Black Diamond Therapeutics Inc | Dr. Alexander Mayweg, PhD | Director | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | ||
| Monte Rosa Therapeutics Inc | Dr. Alexander Mayweg, PhD | Director | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Black Diamond Therapeutics Inc | Dr. Alexander Mayweg, PhD | Director | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) |